Related Experiment Videos
A bisulfite-free intraocular epinephrine solution
J W Slack1, H F Edelhauser, M J Helenek
1Department of Ophthalmology, Medical College of Wisconsin, Milwaukee.
American Journal of Ophthalmology
|July 15, 1990
Summary
A new preservative-free, sulfite-free epinephrine solution shows reduced corneal toxicity for intraocular use. This formulation offers enhanced safety compared to older sulfite-containing epinephrine solutions.
Area of Science:
- Ophthalmology
- Corneal Physiology
- Ophthalmic Drug Development
Background:
- Sulfite-containing epinephrine solutions have been associated with corneal toxicity.
- Epinephrine is used in intraocular irrigating solutions.
Purpose of the Study:
- To evaluate the corneal toxicity of a novel preservative-free, sulfite-free epinephrine solution.
- To compare its safety profile against existing epinephrine formulations.
Main Methods:
- Paired human corneal endothelial perfusion studies were conducted.
- In vivo studies involved direct anterior chamber injection in New Zealand white rabbits.
Main Results:
- The preservative-free, sulfite-free epinephrine solution demonstrated no endothelial toxicity at concentrations up to four times the recommended dilution.
- Significantly less corneal edema was observed in rabbit models compared to sulfite-containing solutions.
Conclusions:
- The preservative-free, sulfite-free epinephrine solution offers reduced endothelial toxicity.
- Low buffer capacity, absence of preservatives, and lack of sulfite contribute to its improved safety margin for intraocular procedures.